Retatrutide

Retatrutide is a next-generation synthetic peptide engineered as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. This tri-agonist architecture enables coordinated modulation of energy intake, insulin dynamics, and energy expenditure, positioning it as a high-value compound in advanced metabolic research.

molecular Specifications

Type: Synthetic triple agonist peptide (GLP-1 / GIP / Glucagon)
Length: ~39 amino acids (engineered analog)
Molecular Weight: ~4.5–4.8 kDa
Structure: Modified incretin–glucagon hybrid sequence
Key Features: DPP-4 resistance, enhanced receptor affinity, extended activity profile
Solubility: Water-soluble
Charge Profile: pH-dependent
Stability: Sensitive to heat, light, and oxidation

COA

RESEARCH USE ONLY (RUO): THIS COMPOUND IS FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, VETERINARY, OR DIAGNOSTIC PURPOSES.